Zosano Pharma - Stock Price History | ZSAN

Historical daily share price chart and data for Zosano Pharma since 2021 adjusted for splits. The latest closing stock price for Zosano Pharma as of September 24, 2021 is 0.71.
  • The all-time high Zosano Pharma stock closing price was 233.40 on March 19, 2015.
  • The Zosano Pharma 52-week high stock price is 3.06, which is 331% above the current share price.
  • The Zosano Pharma 52-week low stock price is 0.33, which is 53.5% below the current share price.
  • The average Zosano Pharma stock price for the last 52 weeks is 0.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zosano Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 0.9135 1.5200 1.8200 0.3362 0.5271 -65.32%
2019 2.7908 2.3400 6.0000 1.3700 1.5200 -28.30%
2018 5.3772 10.6000 18.4900 1.8500 2.1200 -79.62%
2017 24.7799 15.6400 62.4000 10.4000 10.4000 -33.33%
2016 30.1049 47.6020 54.2000 9.0620 15.6000 -65.79%
2015 146.6171 220.2000 233.4000 44.7980 45.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.081B $0.000B
Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71